Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo

Molecular Immunology

Volumn 43, Issue 13, 2006, Pages 2045-2050

  de Jong, Judith M H ^a   Schuurhuis, Danita H ^a   Ioan Facsinay, Andreea ^a   van der Voort, Ellen I H ^a   Huizinga, Tom W J ^a   Ossendorp, Ferry ^a   Toes, René E M ^a   Verbeek, J Sjef ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antigen presentation; CD8+ T cells; Fc Receptors; Immune complexes

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN G; OVALBUMIN; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-ANTIBODY COMPLEX; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COMPLEMENT C3; MICE; MICE, KNOCKOUT; RECEPTORS, COMPLEMENT; RECEPTORS, IGG;

ANIMALIA; MURINAE;

EID: 33645876163     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.01.002     Document Type: Article

References (33)

1. Amigorena S., and Bonnerot C. Fc receptor signaling and trafficking: a connection for antigen processing. Immunol. Rev. 172 (1999) 279-284
2. Antoniou A.N., and Watts C. Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcgammaRII. Eur. J. Immunol. 32 (2002) 530-540
3. Ashman R.F., Peckham D., and Stunz L.L. Fc receptor off-signal in the B cell involves apoptosis. J. Immunol. 157 (1996) 5-11
4. Barnes N., Gavin A.L., Tan P.S., Mottram P., Koentgen F., and Hogarth P.M. FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16 (2002) 379-389
5. Bijsterbosch M.K., and Klaus G.G. Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J. Exp. Med. 162 (1985) 1825-1836
6. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., and Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J. Exp. Med. 196 (2002) 1627-1638
7. Choquet D., Partiseti M., Amigorena S., Bonnerot C., Fridman W.H., and Korn H. Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J. Cell Biol. 121 (1993) 355-363
8. den Haan J.M., and Bevan M.J. Constitutive versus activation-dependent cross- presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J. Exp. Med. 196 (2002) 817-827
9. den Haan J.M., Lehar S.M., and Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192 (2000) 1685-1696
10. Dhodapkar K.M., Kaufman J.L., Ehlers M., Banerjee D.K., Bonvini E., Koenig S., Steinman R.M., Ravetch J.V., and Dhodapkar M.V. Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2910-2915
11. Getahun A., Dahlstrom J., Wernersson S., and Heyman B. IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc gamma receptors. J. Immunol. 172 (2004) 5269-5276
12. Hamano Y., Arase H., Saisho H., and Saito T. Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J. Immunol. 164 (2000) 6113-6119
13. Hazenbos W.L., Gessner J.E., Hofhuis F.M., Kuipers H., Meyer D., Heijnen I.A., Schmidt R.E., Sandor M., Capel P.J., Daeron M., van de Winkel J.G., and Verbeek J.S. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity 5 (1996) 181-188
14. Heath W.R., and Carbone F.R. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1 (2001) 126-134
15. Ioan-Facsinay A., de Kimpe S.J., Hellwig S.M., van Lent P.L., Hofhuis F.M., van Ojik H.H., Sedlik C., da Silveira S.A., Gerber J., de Jong Y.F., Roozendaal R., Aarden L.A., van den Berg W.B., Saito T., Mosser D., Amigorena S., Izui S., van Ommen G.J., van Vugt M., van de Winkel J.G., and Verbeek J.S. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16 (2002) 391-402
16. Jung S., Unutmaz D., Wong P., Sano G., De los S.K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., Pamer E.G., Littman D.R., and Lang R.A. in vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17 (2002) 211-220
17. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8 (1996) 348-354
18. Manca F., Fenoglio D., Li P.G., Kunkl A., and Celada F. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J. Exp. Med. 173 (1991) 37-48
19. Mechetina L.V., Najakshin A.M., Alabyev B.Y., Chikaev N.A., and Taranin A.V. Identification of CD 16-2, a novel mouse receptor homologous to CD16/Fc gamma RIII. Immunogenetics 54 (2002) 463-468
20. Minskoff S.A., Matter K., and Mellman I. Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens. J. Immunol. 161 (1998) 2079-2083
21. Muta T., Kurosaki T., Misulovin Z., Sanchez M., Nussenzweig M.C., and Ravetch J.V. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 369 (1994) 340
22. Nakamura K., and Cambier J.C. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation. J. Immunol. 161 (1998) 684-691
23. Nimmerjahn F., Bruhns P., Horiuchi K., and Ravetch J.V. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 23 (2005) 41-51
24. Probst H.C., Lagnel J., Kollias G., and van den B.M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18 (2003) 713-720
25. Probst H.C., McCoy K., Okazaki T., Honjo T., and van den B.M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6 (2005) 280-286
26. Ravetch J.V., and Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 19 (2001) 275-290
27. Ravetch J.V., and Clynes R.A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16 (1998) 421-432
28. Ravetch J.V., and Kinet J.P. Fc receptors. Annu. Rev. Immunol. 9 (1991) 457-492
29. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Thery C., Rescigno M., Saito T., Verbeek S., Bonnerot C., Ricciardi-Castagnoli P., and Amigorena S. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189 (1999) 371-380
30. Rodriguez A., Regnault A., Kleijmeer M., Ricciardi-Castagnoli P., and Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell. Biol. 1 (1999) 362-368
31. Schuurhuis D.H., Ioan-Facsinay A., Nagelkerken B., van Schip J.J., Sedlik C., Melief C.J., Verbeek J.S., and Ossendorp F. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J. Immunol. 168 (2002) 2240-2246
32. Wagle N.M., Faassen A.E., Kim J.H., and Pierce S.K. Regulation of B cell receptor-mediated MHC class II antigen processing by FcgammaRIIB1. J. Immunol. 162 (1999) 2732-2740
33. Yada A., Ebihara S., Matsumura K., Endo S., Maeda T., Nakamura A., Akiyama K., Aiba S., and Takai T. Accelerated antigen presentation and elicitation of humoral response in vivo by Fcgamma. Cell. Immunol. 225 (2003) 21-32